160 related articles for article (PubMed ID: 38126949)
21. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
22. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.
Rojas A; Zhang P; Wang Y; Foo WC; Muñoz NM; Xiao L; Wang J; Gores GJ; Hung MC; Blechacz B
Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026
[TBL] [Abstract][Full Text] [Related]
23. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
[TBL] [Abstract][Full Text] [Related]
24. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis.
Wu MZ; Yuan YC; Huang BY; Chen JX; Li BK; Fang JH; Zhuang SM
Signal Transduct Target Ther; 2021 Nov; 6(1):395. PubMed ID: 34785655
[TBL] [Abstract][Full Text] [Related]
25. Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-
Bai L; Ge P; Zhang Y; Song Y; Xing R; Zhou D
Biomed Res Int; 2022; 2022():1080315. PubMed ID: 36158877
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis via the TGF-β1/SMAD3 Pathway
Wang S; He L; Xiao F; Gao M; Wei H; Yang J; Shu Y; Zhang F; Ye X; Li P; Hao X; Zhou X; Wei H
J Clin Transl Hepatol; 2023 Feb; 11(1):1-14. PubMed ID: 36406310
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF
Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321
[TBL] [Abstract][Full Text] [Related]
28. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
[TBL] [Abstract][Full Text] [Related]
29. EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients.
Dai Y; Tang Z; Yang Z; Zhang L; Deng Q; Zhang X; Yu Y; Liu X; Zhu J
Cell Cycle; 2018; 17(19-20):2386-2397. PubMed ID: 30328366
[TBL] [Abstract][Full Text] [Related]
30. TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.
Dropmann A; Dediulia T; Breitkopf-Heinlein K; Korhonen H; Janicot M; Weber SN; Thomas M; Piiper A; Bertran E; Fabregat I; Abshagen K; Hess J; Angel P; Coulouarn C; Dooley S; Meindl-Beinker NM
Oncotarget; 2016 Apr; 7(15):19499-518. PubMed ID: 26799667
[TBL] [Abstract][Full Text] [Related]
31. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
[TBL] [Abstract][Full Text] [Related]
32. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.
Li ZJ; Ou-Yang PH; Han XP
Cell Signal; 2014 Jan; 26(1):141-8. PubMed ID: 24100264
[TBL] [Abstract][Full Text] [Related]
33. Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.
Xu XY; Du Y; Liu X; Ren Y; Dong Y; Xu HY; Shi JS; Jiang D; Xu X; Li L; Xu ZH; Geng Y
Cell Commun Signal; 2020 Sep; 18(1):151. PubMed ID: 32933544
[TBL] [Abstract][Full Text] [Related]
34. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
35. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
Nomair AM; Kandil LS; Nomeir HM; Kandil NS
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation.
Ma L; Zeng Y; Wei J; Yang D; Ding G; Liu J; Shang J; Kang Y; Ji X
Biomed Pharmacother; 2018 Nov; 107():1728-1735. PubMed ID: 30257391
[TBL] [Abstract][Full Text] [Related]
37. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
38. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
39. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
Zhou LH; Chen X
Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
